Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.

Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a deployment of the latest platform version. No study data or history entries were modified.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new software release. This update does not modify any study data or the history content.SummaryDifference0.0%

- Check56 days agoChange DetectedThe revision tag in the page footer updates from v3.6.2 to v3.6.3, signaling a new UI release without altering the study record content.SummaryDifference0.0%

- Check63 days agoChange DetectedA new site revision label v3.6.2 was added and the previous v3.6.0 entry was removed from the history display.SummaryDifference0.0%

- Check78 days agoChange DetectedRecruitment status now shows 'No longer looking for participants', clarifying that the study is not enrolling. The revision label has updated to v3.6.0, with v3.5.5 removed.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page history now shows Revision: v3.5.5, replacing Revision: v3.5.4. This indicates a minor update to the page's metadata or rendering without altering core content.SummaryDifference0.0%

Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.